Učitavanje...
Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
Background. Peroxisome proliferator-activated receptor-α (PPAR-α) is closely associated with the development of cardiac hypertrophy. Previous studies have indicated that bezafibrate (BZA), a PPAR-α agonist, could attenuate insulin resistance and obesity. This study was designed to determine whether...
Spremljeno u:
| Izdano u: | PPAR Res |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Hindawi Publishing Corporation
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5239981/ https://ncbi.nlm.nih.gov/pubmed/28127304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5789714 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|